Concord Wealth Partners Perkinelmer Inc Transaction History

Concord Wealth Partners

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Apr 30, 2024	BUY	$115.88 - $122.81 $2,317 - $2,456	20 New	20 $2,000
Q2 2023 Aug 07, 2023	BUY	$0.0 - $137.11 $0 - $2,742	20 New	20 $0
Q4 2022 Jan 27, 2023	BUY	$119.0 - $147.98 $2,380 - $2,959	20 New	20 $2,000
Q2 2022 Aug 04, 2022	SELL	$134.91 - $172.49 $14,975 - $19,146	-111 Reduced 84.73%	20 $3,000
Q1 2022 Apr 20, 2022	BUY	$162.31 - $192.2 $1,136 - $1,345	7 Added 5.65%	131 $23,000
Q4 2021 Jan 21, 2022	BUY	$166.66 - $201.06 $16,999 - $20,508	102 Added 463.64%	124 $25,000
Q3 2021 Nov 09, 2021	SELL	$151.98 - $190.5 $13,678 - $17,145	-90 Reduced 80.36%	22 $4,000
Q2 2021 Jul 29, 2021	BUY	$127.81 - $155.84 $1,661 - $2,025	13 Added 13.13%	112 $17,000
Q1 2021 May 13, 2021	BUY	$120.35 - $160.53 $11,914 - $15,892	99 New	99 $13,000

575

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.